Related Experiment Video
Updated: Jan 24, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
[Cancers and multiple sclerosis: risk of comorbidity and influence of disease modifying therapy]
1Pirogov Russian State Research Medical University, Moscow, Russia.
Abstract:
Data of clinical-epidemiological studies on the risk of cancer in patients with multiple sclerosis (MS) are discussed. A trend towards increased risks of brain tumors and urological cancers has been shown. The author considers risk factors, including disease modifying therapies (DMT), for different cancers. It has been concluded that longitudinal observational and large cohort studies along with MS registers are needed to clarify a role of DMD in the development of malignant neoplasms.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Gene Therapy
Multiple Allele Traits
Relative Risk

